# A Multicenter, Real-world Study of Adebrelimab in the Treatment of Extensive Stage Small Cell Lung Cancer

> **NCT06267170** · — · UNKNOWN · sponsor: **Henan Cancer Hospital** · enrollment: 288 (estimated)

## Conditions studied

- SCLC,Extensive Stage

## Interventions

- **DRUG:** Adebrelimab

## Key facts

- **NCT ID:** NCT06267170
- **Lead sponsor:** Henan Cancer Hospital
- **Sponsor class:** OTHER_GOV
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2024-02-25
- **Primary completion:** 2025-02-25
- **Final completion:** 2026-02-25
- **Target enrollment:** 288 (ESTIMATED)
- **Last updated:** 2024-02-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06267170

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06267170, "A Multicenter, Real-world Study of Adebrelimab in the Treatment of Extensive Stage Small Cell Lung Cancer". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT06267170. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*